Menu
Contact Us
Search
GO
Why Choose Us
Innovative Approaches
Conditions
Centers & Programs
For Families
For Physicians
News
Find a Doctor
Contact Us
Clinical Trials
Directions and Parking
News
Find a Doctor
Contact Us
Clinical Trials
Directions and Parking
Why Choose Us
Expertise
Survivorship
Global Health
Leadership
History and Milestones
Innovative Approaches
CAR T-Cell Therapy
Clinical Trials for Relapsed Cancer
Gene Therapy
Immunotherapy for Children
MIBG Therapy
Pediatric Cancer Genetic Risk Program
Precision Medicine
Stem Cell Transplant
Conditions
Blood Disorders
Brain Tumors
Leukemia, Lymphoma, and Histiocytosis
Solid Tumors
Other Conditions We Treat
Centers & Programs
Blood Disorders Center
Brain Tumor Center
Hematologic Malignancy Center
Solid Tumor Center
For Families
Become a Patient
Insurance and Financial Information
Our Facilities
Patient & Family Advisory Council
Patient and Family Support Services
Five Things Parents Should Know
Childhood Cancer Awareness Month
Education Resources
For Physicians
Referrals and Second Opinions
Clinical Trials & Research
Research Labs
Fellowship Overview
Affiliations and Consortia
Continuing Medical Education
Newsletter Sign Up
Home
>
Share
Print
Print
Sitemap
Dana Farber Childrens Hospital
Dana Farber Boston Children s Cancer and Blood Disorders Center launches new website
Seminar: Causes and effects of the shortage of oncology drugs
The High Price of Tanning
Optimism about Pediatric Cancer Care
Teaming with our twin in India, to take on hemophilia
Overcoming Drew’s blood disorder, together
Research registry reveals new mutations in rare childhood blood disorders
Summer Fun for Kids with Cancer
New Diller study
Dangers of Tanning Beds
Gene therapy’s time seems to have come
Childhood Cancer Awareness Month
About-Us
Media Relations Policy
ReadyCam Studio
Gene Therapy Trial for Bubble Boy Syndrome
New Procedures Help Pediatric Cancer Patients With Future Fertility
Haematopoietic Stem Cell Transplants
Teenager Raises Thousands to Help Children with Vascular Anomalies
Five Things Parents of Children with Cancer Should Know
After Cancer Fertility Is Often Within Reach
The Survivorship Care Gap: After Childhood and AYA Cancers, How to Keep Survivors in Follow-Up Care
How to Help Your Child if a Classmate Has Cancer
Martin Walsh's Childhood Marked by Cancer Fight
Patricia Branowicki Elected to American Academy of Nursing
'Care Bundle’ Prevents Central Line-Associated Bloodstream Infections in Ambulatory Pediatric Cancer Patients
Young Warrior Shares His Story
Dana-Farber/Boston Children’s physicians among Boston Magazine’s Top Doctors 2013
International gene therapy trial for bubble boy disease shows promising early results
Rare cause of anemia in newborns often overlooked
Less Painful Drug Delivery for Pediatric Leukemia Patients is Safe, Effective, Research Suggests
Discovery holds promise for bubble boy patients
Gene therapy keeps bubble boy disease at bay in 8 children
My Sportsman: Nebraska Fan Jack Hoffman
Bubble Boy Disease Could Have a Cure
Mom, Son Battle Cancer Together with Inspiration and Teamwork
Study: Eating Nuts in Pregnancy May Lower Child’s Allergy Risk
Gisele Bundchen Visits Young Malden Girl Battling Cancer
Antipsychotic Drug Exhibits Cancer-Fighting Properties
Forbes Names Scientist One of “30 under 30” to Watch
Fertility After Treatment for Childhood Cancer
Fertility Among Survivors of Childhood Cancer
Lives Less Ordinary
Mutation Discovery May Improve Treatment for Rare Brain Tumor Type
Perseverance On and Off the High School Basketball Court
Sick Kids Need Faster Drug Testing
Long-term Survival Among Patients with Most Common Childhood Brain Tumor is High
Normal Enzyme Aids a Mutant One to Fuel Blood Cancer’s Growth
Alisha’s Strength Drives Cancer Fight
Hope Grows for Sickle Cell Disease Patients
Vermont Girl Gets Second Bone Marrow Transplant
Sick Vt. Kids Highlight Need for Bone Marrow Donors
Attleboro Police Make Room for a Middleborough Boy with Cancer
NH Boy Adopted from Ethiopia Finds Bone Marrow Match with African Siblings
Scientists Find Potential Drug Targets in Deadly Pediatric Brain Tumors
Caring for a Central Line (Spanish)
Caring for a Central Line (Arabic)
Gene Linked to Pediatric Kidney Cancer Suggests New Strategies for Kidney Regeneration
Physician Advocates for Palliative Care Bill on Beacon Hill
High School Athlete Shows Strength On-field and Off
Medical Education to Fight Global Cancer
Children with Low-grade Glioma Enjoy Long-term Survival
Nurse Lauded for Efforts with Patients
Siblings Arrive from Ethiopia to Try and Save Brother's Life
Researchers Uncover Link Between Down Syndrome and Childhood Leukemia
Billerica High Cell-out to Help Boy with Leukemia Worthy of a Standing ‘O’
University Rallies for Student Fighting Cancer
In Children with Cancer, Navy SEALS Find “Like-Minded” Warriors
Training Community-Based Pediatricians in Palliative Care
Other Pediatric Conditions We Treat
Preventing Infections in Outpatients Caring for Central Lines at Home
Study Calls for Revisiting Guidelines for Screening Childhood Cancer Survivors at Risk of Congestive Heart Failure
US News Names Dana-Farber Boston Children’s #1
Mayor Walsh Reflects on his Childhood Cancer before Audience of Cancer Survivors
Global Health Statistics
Where We Work
Who We Are
Nursing
What We Do
Psychosocial Support
Cancer Can’t Stop this Dorchester Teenager
In Cancer’s Aftermath, Young Adults Find Support from Each Other
A Young Cancer Patient’s Take on “The Fault in Our Stars”
Exploring Scorpion Venom’s Potential to Treat Cancer
Just 16, Karina Moreira Battles Cancer in her Own Style
Researchers Say Study Underscores Importance of Newborn Screening for “Bubble Boy” Disease
Niña Batalla por Garnale al Cancer
The Gospel of Calle
Newly Discovered Gene Regulator Could Precisely Target Sickle Cell Disease
Survivors of Pediatric Brain Tumors Share a Special Bond
Dr Joanne Wolfe wins American Cancer Society Pathfinder Award
Bluebird Bio Advances Experimental Drug for Genetic Brain Disorder
Using a Nasogastric Tube
Caring for a Central Line at Home (English)
Tips for Primary Care Physicians Treating Survivors of Childhood Cancer
Questions to Ask When Your Child Finishes Cancer Treatment
What to Do if Your Child Relapses
As Pediatric Cancer Survivors, Mother and Daughter Share Unique Bond
More Children Are Developing Cancer But Fewer Are Dying
A patient and doctor team come full circle
Five Ways to Support Families Dealing with Childhood Cancer
Determined to Get Back in the Game
Cancer Diagnosis Cant Shake These First-time Parents
New Research Shows Promise for Pediatric Brain Tumor Treatment
Boston Mayor Marty Walsh Proud to be a Cancer Survivor
Common Genetic Variations May Contribute to Treatment-related Cognitive Problems in Children with Leukemia
Stem Cell Transplant without Radiation or Chemotherapy Pre-treatment Shows Promise for Rare Bone Marrow Failure
Pediatric Neuro-Oncology Clinical Fellowship
The Bad Disease: Inside Egypt’s Children’s Cancer Hospital
Unlocking the Secrets of Pediatric Cancers can Help Doctors Treat Children and Adults
Nine-year-old with Brain Tumor gets to Finish Concert with Friends
Q&A with David Williams
Family of Infant with AML Goes Home for Christmas
Pathology in Global Health
Gene Therapy for “Bubble Boy” Disease Appears to be Effective and Safe
Blood Work
A Child Saved Becomes a Teen Hunting for Cures
Parents of Late Quincy Teen Watch “Fault in Our Stars” with Her Providers
Liberia’s Response to Ebola
David G. Nathan, MD, Wins Boston Children’s Hospital Inaugural Lifetime Impact Award
Researchers Take New Approach to Stop ‘Most Wanted’ Cancer Protein
Working with Adult Survivors of Childhood Cancers
Imaging Captures How Blood Stem Cells Take Root
Cancer Care for the Developing World
Boston Hospitals Pave Way for Precision Medicine
Five Things Pediatricians Should Know About Children Who’ve Had Cancer
Palliative Care Eases the Burden of Serious Illness
The Late Effects of Childhood Cancer
Phase I Trial of Immunotherapy Opens for Children with Relapsed or Treatment-resistant Leukemia
El Salvador
Liberia
Central America
Myanmar
Discussing Child’s Cancer Prognosis More Likely to Produce Peace of Mind and Decrease Anxiety in Parents
Request an Appointment
Refer a Patient
Find Doctor Details
Find Doctor Results
Clinical Trials Results
Clinical Trials Detail
Survivorship Care: David B. Perini Jr. Quality of Life Clinic
Transition Off Therapy: Care After Pediatric Cancer Treatment
Your Primary Team
Promising Drug Target Identified in Medulloblastoma
Guatemala
MyResults
Solid Tumor Center
Brain Tumor Center
Blood Disorders Center
Leukemia, Lymphoma, and Histiocytosis
General Inquiries
Solid Tumors
Blood Disorders
Brain Tumors
Blood Transfusions
Chemotherapy
Imaging
Genetic Testing
Radiation Therapy
Surgery
MIBG Therapy
Pathology
Gene Therapy
Hematologic Malignancy Center
Pediatric Cancer Genetic Risk Program
Pediatric Advanced Care Team
Pediatric Fertility Preservation Program
Psychosocial Services
Williams honored for Outstanding Achievement by ASGCT
International Gene Therapy Trial Launched at Children's Hospital Boston
Potential gene therapy approach to sickle cell disease highlighted at ASH
The American Society of Hematology Elects New Leadership
Alex's Lemonade Stand Foundation awards $1.75 million grant to Dana-Farber Boston Children's Cancer and Blood Disorders Center
National Academy of Sciences honors Dana-Farber Boston Children's Cancer and Blood Disorders Center's Orkin
Drug shortage linked to greater risk of relapse in young Hodgkin lymphoma patients
Justin Bieber Dream Date Shines Light on Rare Pediatric Cancer
American Association for Cancer Research honors D'Andrea
Key mutations discovered for most common childhood brain cancer
Dana-Farber/Children's Hospital Cancer Center establishes training program with Egypt Cancer Network and Children's Cancer Hospital Egypt
Intensified chemotherapy shows promise for children with very high-risk form of leukemia
Precision Medicine
Immunotherapy for Children
Brain Tumor Survivorship
Interventional Radiology
Directions and Parking
What's in a name
A new, faster route for pediatric clinical trials
Revealing new mutations in pediatric myelodysplastic syndromes
Delays in diagnosis worsen outlook for minority, uninsured pediatric retinoblastoma patients, study finds
Majority of children readmitted to hospital following transplant
Building a community around vascular anomalies research
Scientists find mutation driving pediatric brain tumors
U.S. News Names Dana-Farber Boston Children’s #1 Pediatric Cancer Program
Philippines
Ethiopia
Rwanda
Dominican Republic
Second Opinions
Mexico
Disparities in Outcomes for Children with Rare Eye Cancer Suggest Unequal Access to Primary Care
Study Uses Gene Editing to Take Brakes Off Lab-based Red Blood Cell Production
Precision Medicine Infographic
Clinical Trials for Relapsed Cancer
Children with Childhood Leukemia Benefit from Prophylactic Antibiotics
Early Gene Therapy Results in Wiskott-Aldrich Syndrome Promising
Therapy Directed Against Platelets Does Not Significantly Reduce Painful Crises in Sickle Cell Disease
Studies highlight new drug targets or compounds for acute myeloid leukemia
Special holiday concert features young violinist and surgeon who removed her brain tumor
More than two-thirds of teen and young adult cancer patients facing end of life use aggressive measures
Genetic Sequencing Can Help Guide Treatment in Children with Solid Tumors
Genetic Cause Identified in Rare Pediatric Brain Tumor
In Precision Medicine, Pioneering Young Patient Teaches Veteran Doctor
Childhood leukemia patients from high-poverty areas more likely to suffer early relapse
Study explores how high-fat diet influences colon cancer
Amazing Allison: A young 'pioneer' and the Boston doctors who saved her
Armenia
The Coalition for Pediatric Medical Research: Recommended Pediatric Priorities for the Cancer Moonshot Initiative
Making a difference: Treating sickle cell disease in Liberia
Young adult survivors of childhood cancer report
Evidence suggesting link between cancer and light therapy
Q & A: Making sense of new research on possible link between phototherapy for newborn jaundice and cancer
Brave boy donates bone marrow to sister fighting leukemia
Science commentary explores ways to pay for success in gene therapy
Genetic treatments for sickle cell
We’ve known for 50 years what causes sickle cell disease. Where’s the cure?
Dual stem-cell transplant improves outlook for children with high-risk neuroblastoma
Dana-Farber Boston Children’s remains nation’s #1 pediatric cancer program
Make children’s cancer research a ‘moonshot’ priority
How drug companies use gifts and internships to reach valuable hemophilia patients
America is great at beating childhood cancer and it’s about to get better
What the cancer moonshot might mean for kids
Patriots’ Nate Solder seeks normalcy after hellish year
Childhood cancer deaths: Brain cancer overtakes leukemia as top cause
Finally, hope for a young patient with CGD
Fighting genetic disease with help of HIV virus
Research into basic workings of immune system points to way of improving therapies for cancer and chronic infection
Scientists tackle DIPG, a lethal childhood brain cancer
Gene therapy offers hope for treatment of sickle cell anemia
Boston Children’s hires a chief scientific officer
The role of early phase clinical trials in end-of-life care for children
Intimate photos show young Guatemalan boy’s journey through cancer
Os pequenos herois que venceram o cancer
Children with Down syndrome and acute lymphoblastic leukemia
Deaths in cancer trials remain mystery for promising therapy
Pioneering doctor reflects on gene therapy’s trajectory
Sickle cell disease: An unpredictable adversary
Applying local knowledge
Gene therapy trial gives Coopersville toddler second chance at life
Egypt
What Are the Differences Between Adult and Childhood Brain Tumors?
What Specialists Does a Child See When Diagnosed with Cancer?
What You Need to Know for Life After Childhood Cancer Treatment
Reducing the toxicity of cancer treatment
Mahra Beats Cancer and Avoids Amputation
Infographic-four-things-you-need-to-know-about-childhood-cancer
Haiti
Four Things on the Horizon
Gene Editing Study Reveals Possible Achilles Heel of Sickle Cell Disease
Almost One Third of Families of Children with Cancer Have Unmet Basic Needs During Treatment
Gene therapy trial wrenches families as one child’s death saves another
Biden should take a note from the original moonshot: Focus on just one cancer
Finding a cure wouldn’t mean we’ve defeated cancer
Outpatient bloodstream infections costly for pediatric stem cell transplant and cancer patients
Precision medicine advances pediatric brain tumor diagnosis and treatment
In overhauling Obamacare the details matter
It’s not an even playing field
Travel dreams fulfilled for 9-year-old with terminal cancer
Stem-cell-derived cells flag possible new treatment for Diamond-Blackfan anemia
From moving mountains to climbing mountains, Fulton native seeks to redefine ‘possible’
The Lifesaving Care Act
Martial arts instructors volunteer with kids fighting cancer
One boy’s cure raises hopes and questions about gene therapy for sickle cell disease
How a child made scientists think of cytokines as knobs instead of switches
How dogs may help fight bone cancer
MIT Tech Review gene therapy
Dana-Farber/Boston Children's again named a top national pediatric cancer program
Novel CRISPR-Cas9 genetic screening approach enables discovery of new drug targets to aid cancer immunotherapy
Dana-Farber/Boston Children's responds to FDA approval of CAR-T cell therapy
Gene therapy halts progression of cerebral adrenoleukodystrophy in clinical trial
Two Dana-Farber/Boston Children's faculty members elected to National Academy of Medicine
A new gene therapy transplantation technique could improve treatment of neurodegenerative disease
Bursting with gene therapies and other innovative treatments, the overall survival rate for our blood and marrow transplant patients is exceeding expectations
Dana-Farber/Boston Children’s researcher is part of a new Stand Up To Cancer campaign with Marvel Studios’ Avengers and American Airlines
Pioneering hematologist to receive 2018 Nemmers Prize in Medical Science
Dana-Farber/Boston Children's again ranked among the top national pediatric cancer programs
BCL11A-based gene therapy for sickle cell disease passes key preclinical test
Discovery offers prospect of shorter treatment and cure for chronic myelogenous leukemia
Leslie Kean, MD, PhD, joins Dana-Farber/Boston Children's Stem Cell Transplantation program
MATCHing precision medicine to all kids with cancer
Fishing for new leads in rare mucosal melanoma
In zebrafish, a way to find new cancer therapies, targeting tumor promoters
Solving the DIPG puzzle a single cell at a time
Probing the brain’s earliest development, with a detour into rare childhood cancers
A bold strategy to enhance CAR T-cell therapies, capable of targeting DIPG and other tough-to-treat cancers
Zeroing in on the fetal-to-adult hemoglobin switch and a new way to combat sickle cell disease
A breakthrough in our understanding of how red blood cells develop
Cancer researchers hit a bullseye with a new drug target for Ewing sarcoma
Dulling cancer therapy’s double-edged sword: A new way to block tumor recurrence
New gene therapy strategy for sickle cell disease shows early promise in humans
How I Live
Boston Children’s Hospital to receive $1.5M to initiate basic work to expand gene therapy treatment of sickle cell disease into developing countries
CRISPR-Cas9 screen opens new targets for Ewing sarcoma, other childhood cancers
Current Region-Wide Initiatives
Multi-center study led by Dana-Farber/Boston Children's contributes to FDA approval of a new treatment for acute lymphoblastic leukemia
Transplants from any donor without toxicity
Scott Armstrong, MD, PhD, recognized by ISSCR for contributions to basic and translational research in hematological disorders
Dana-Farber/Boston Children's Brian D. Crompton, MD, awarded research grant by the Go4theGoal Foundation
Researchers at Dana-Farber/Boston Children's and UMass Medical School optimize gene editing for sickle cell disease and beta thalassemia
Giving Medications Safely at Home (English)
Giving Medications Safely at Home (Spanish)
Giving Medications Safely at Home (Arabic)
Children with cancer wait an average of 6.5 years longer than adults to access new targeted drugs, finds study at Dana-Farber/Boston Children’s
Lynda M. Vrooman to present findings from Dana-Farber/Boston Children’s clinical trial that led to FDA approval of novel drug for treatment of ALL in young patients
Team led by Dana-Farber/Boston Children’s Kimberly Stegmaier receives SU2C Sharp Award from Stand Up To Cancer
Katherine E. Warren, MD, joins Dana-Farber/Boston Children’s as Clinical Director for Pediatric Neuro-Oncology
Dana-Farber/Boston Children's nation’s #1 pediatric cancer program
Leonard Zon, MD, honored by the American Society of Hematology for Outstanding Mentorship
Dana-Farber/Boston Children's launches first DIPG Brain Tumor Consortium
Dana-Farber/Boston Children’s Hojun Li named a 2020 Scholar Award Recipient by the American Society of Hematology
Dana-Farber/Boston Children’s faculty named 2020 Top Doctors
CAR T-Cell Therapy
Stuart Orkin named 2020 King Faisal Prize Laureate in Medicine
Day One Talk Videos
The Osteosarcoma Institute to fund clinical trial in recurrent osteosarcoma at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
Shimamura named recipient of the 2020 Frank A. Oski Memorial Lectureship from ASPHO
Count Me In launches Osteosarcoma Project
Hass-Kogan receives funding for new DIPG-specific research project from Defeat DIPG and ChadTough
Dana-Farber/Boston Children’s receives $200,000 grant from Hyundai Hope On Wheels to support COVID-19 testing
Bauer earns Outstanding New Investigator Award from ASGCT
Massive study reveals how 'hypermutated' malignant brain tumors with many mutations escape chemotherapy and immunotherapy
2020 Harrington Prize awarded to Dr. Stuart H. Orkin
Pioneering a ‘Staple’ Approach for Treating COVID-19
Pediatric neurosurgeon Lissa Baird, MD, joins Dana-Farber/Boston Children’s
Population-based registry data identifies novel cancer patterns in families of childhood cancer patients
Dana-Farber/Boston Children's named a top pediatric cancer program
Amazon surprises Dana-Farber/Boston Children’s with a $500,000 donation during Childhood Cancer Awareness Month
Stem Cell Transplant
Dana-Farber/Boston Children's Faculty Named 2021 Top Doctors
Stuart H. Orkin Receives the 2021 ISSCR Tobias Lecture Award
In landmark study, an arthritis drug appears to prevent deadly acute graft-versus-host disease after bone marrow transplant
Targeted therapy for children with leukemia can provide substantial benefit, study finds
Stuart Orkin receives $500,000 Gruber Genetics Prize for his groundbreaking research on the genetics of inherited blood disorders
Childhood cancer survivors, providers satisfied with video visits for long-term follow-up
Alex’s Lemonade Stand Foundation awards $4.95 million to Dana-Farber/Boston Children’s researchers as part of its Crazy 8 Initiative to advance pediatric cancer research
Vietnamese boy thrives after gene therapy for Wiskott-Aldrich syndrome
The space between heartache and happiness: Two sons with adrenoleukodystrophy and a gene therapy clinical trial
New gene therapy clinical trial offers hope for sickle cell disease
“Stapled” antimicrobial peptides could combat antibiotic resistance
A. Thomas Look, MD, awarded 2021 Society of Memorial Sloan Kettering Prize recipient for contributions in pediatric oncology
Dana-Farber/Boston Children's again named a top pediatric cancer program
Stuart Orkin and Daniel Bauer receive funding for sickle cell disease research from the Doris Duke Charitable Foundation
International Patient Services
Back to School Support
Referrals and Second Opinions
Clinical Training
Expertise
Become a Patient
Clinical Trials & Research
Insurance and Financial Information
Participating in Clinical Trials
Research and Training
Resource Centers
Five Things Parents Should Know
Sibling Program
How to Apply
Preparing for Your First Visit
Childhood Leukemia, Lymphoma, and Histiocytosis
Continuing Medical Education
Our Facilities
OBSOLETE - Types of Brain Tumors
Our Fellowship Program
MyChildren's Patient Portal
Leadership
Our eNewsletter
Patient & Family Advisory Council
Patient and Family Support Services
Affiliations and Consortia
Brain Tumor Survivorship
Fellows of 2014
Childhood Cancer Awareness Month
Consultations and Second Opinions
Global Health Initiative
International Society of Paediatric Oncology (SIOP) - 2020
Education Resources
Survivorship
Centers & Programs
Fellows of 2015
American Society of Pediatric Hematology/Oncology Conference - 2021
Privacy
Fellows of 2016
History and Milestones
2017 Pediatric Hematology/Oncology Fellows
Flexibility and Special Programs
World-class Childhood Cancer Care
Fellowship Program Leadership
Clinical Trials for Childhood Cancer and Blood Disorders
Diversity and Inclusion
Sickle Cell Disease Treatment for Children
Meet Our Fellows
Fellow Life
Salary and Benefits
Faculty and Fellow Publications on Diversity, Equity, and Inclusion
Second Opinions
2018 Pediatric Hematology/Oncology Fellows
MoreThanYouSee
Carlie is More Than You See
Dylan is More Than You See
Carter climbs to new heights after rotationplasty
Teaghan swims through leukemia treatment
Why Choose Us
Contact Us
Global Health Statistics
Where We Work
Who We Are
Nursing
What We Do
Psychosocial Support
Questions to Ask When Your Child Finishes Cancer Treatment
What to Do if Your Child Relapses
As Pediatric Cancer Survivors, Mother and Daughter Share Unique Bond
More Children Are Developing Cancer But Fewer Are Dying
A patient and doctor team come full circle
Boston Mayor Marty Walsh Proud to be a Cancer Survivor
Pathology in Global Health
Blood Transfusions
Chemotherapy
Imaging
Radiation Therapy
Surgery
Pathology
Pediatric Advanced Care Team
Pediatric Fertility Preservation Program
Psychosocial Services
Brain Tumor Survivorship
Interventional Radiology
Survivorship Care: David B. Perini Jr. Quality of Life Clinic
Transition Off Therapy: Care After Pediatric Cancer Treatment
For Physicians
Your Primary Team
Guatemala
El Salvador
Liberia
Central America
Myanmar
Philippines
Ethiopia
Rwanda
Dominican Republic
Egypt
What You Need to Know for Life After Childhood Cancer Treatment
Reducing the toxicity of cancer treatment
Haiti
Mexico
Armenia
How I Live
Current Region-Wide Initiatives
Day One Talk Videos
Global Health Initiative
Why Choose Us
History and Milestones
Expertise
Pediatric Fertility Preservation Program
Your Primary Team
Imaging
Pathology
Surgery
Interventional Radiology
Radiation Therapy
Chemotherapy
Blood Transfusions
Psychosocial Services
Pediatric Advanced Care Team
Fertility Preservation
Survivorship
Questions to Ask When Your Child Finishes Cancer Treatment
What to Do if Your Child Relapses
As Pediatric Cancer Survivors, Mother and Daughter Share Unique Bond
More Children Are Developing Cancer But Fewer Are Dying
A patient and doctor team come full circle
Boston Mayor Marty Walsh Proud to be a Cancer Survivor
Survivorship Care: David B. Perini Jr. Quality of Life Clinic
Transition Off Therapy: Care After Pediatric Cancer Treatment
For Physicians
What You Need to Know for Life After Childhood Cancer Treatment
Reducing the toxicity of cancer treatment
Transition Off Therapy
Survivorship Care
Questions to Ask When Your Child Finishes Cancer Treatment
What to Do if Your Child Relapses
As Pediatric Cancer Survivors, Mother and Daughter Share Unique Bond
More Children Are Developing Cancer But Fewer Are Dying
A patient and doctor team come full circle
Boston Mayor Marty Walsh Proud to be a Cancer Survivor
What You Need to Know for Life After Childhood Cancer Treatment
Reducing the toxicity of cancer treatment
Brain Tumor Survivorship
Global Health
Nursing
Psychosocial Support
Pathology in Global Health
Guatemala
El Salvador
Liberia
Central America
Myanmar
Philippines
Ethiopia
Rwanda
Dominican Republic
Egypt
Haiti
Mexico
Armenia
How I Live
Current Region-Wide Initiatives
Day One Talk Videos
What We Do
Psychosocial Support
Pathology in Global Health
Nursing
Where We Work
Guatemala
El Salvador
Liberia
Central America
Myanmar
Philippines
Ethiopia
Rwanda
Dominican Republic
Egypt
Haiti
Mexico
Armenia
Current Region-Wide Initiatives
Who We Are
GLOBE Program
Global Health Statistics
Contact Us
News
Leadership
Innovative Approaches
Innovative Approaches
Genetic Testing
Immunotherapy for Children
Precision Medicine Infographic
Clinical Trials for Relapsed Cancer
In Precision Medicine, Pioneering Young Patient Teaches Veteran Doctor
CAR T-Cell Therapy
Clinical Trials for Relapsed Cancer (ACCT Clinic)
Gene Therapy
What is Gene Therapy?
Gene Therapy FAQs
Clinical Trials
Immunotherapy
MIBG Therapy
Pediatric Cancer Genetic Risk Program
Genetic Testing
Precision Medicine
In Precision Medicine, Pioneering Young Patient Teaches Veteran Doctor
Precision Medicine Infographic
In Precision Medicine, Pioneering Young Patient Teaches Veteran Doctor
Stem Cell Transplant
Conditions
Other Pediatric Conditions We Treat
Blood Disorders
Immune Thrombocytopenia
Brain Tumors
Leukemia, Lymphoma, and Histiocytosis
Solid Tumors
Centers & Programs
What Are the Differences Between Adult and Childhood Brain Tumors?
New Research Shows Promise for Pediatric Brain Tumor Treatment
Childhood Leukemia, Lymphoma, and Histiocytosis
OBSOLETE - Types of Brain Tumors
Brain Tumor Survivorship
Consultations and Second Opinions
Blood Disorders Center
Our Hematologists
Types of Blood Disorders
Programs
Clinical Trials
Research & Innovation
Brain Tumor Center
New Research Shows Promise for Pediatric Brain Tumor Treatment
What Are the Differences Between Adult and Childhood Brain Tumors?
OBSOLETE - Types of Brain Tumors
Brain Tumor Survivorship
Consultations and Second Opinions
Brain Tumor Specialists
Types of Brain Tumors
What Are the Differences Between Adult and Childhood Brain Tumors?
Programs
Clinical Trials
New Research Shows Promise for Pediatric Brain Tumor Treatment
Survivorship
Consultations
Hematologic Malignancy Center
Childhood Leukemia, Lymphoma, and Histiocytosis
About Our Center
Hematologist/Oncologists
Conditions We Treat
Programs
Clinical Trials
Cancer Survivorship
Solid Tumor Center
Our Treatment Team
Types of Solid Tumors
Programs
Bone & Soft Tissue Program
Liver Tumor Program
Neuroblastoma Program
Rare Tumors Program
Retinoblastoma Program
Kidney Tumor Program
Ocular Oncology Program
Clinical Trials
Cancer Survivorship
For Families
Childhood Cancer Awareness Month
Caring for a Central Line (Spanish)
Caring for a Central Line (Arabic)
Five Ways to Support Families Dealing with Childhood Cancer
Determined to Get Back in the Game
Cancer Diagnosis Cant Shake These First-time Parents
What Specialists Does a Child See When Diagnosed with Cancer?
Mahra Beats Cancer and Avoids Amputation
Infographic-four-things-you-need-to-know-about-childhood-cancer
Four Things on the Horizon
Giving Medications Safely at Home (English)
Giving Medications Safely at Home (Spanish)
Giving Medications Safely at Home (Arabic)
Using a Nasogastric Tube
Caring for a Central Line at Home (English)
Back to School Support
International Patient Services
Participating in Clinical Trials
Resource Centers
Preparing for Your First Visit
Five Things Parents Should Know
Sibling Program
MyChildren's Patient Portal
Patient & Family Advisory Council
Childhood Cancer Awareness Month
Become a Patient
International Patient Services
Participating in Clinical Trials
Preparing for Your First Visit
MyChildren's Patient Portal
Insurance and Financial Information
Our Facilities
Patient & Family Advisory Council
Patient and Family Support Services
Back to School Support
Resource Centers
Sibling Program
Education Resources
Using a Nasogastric Tube
Caring for a Central Line at Home (English)
Caring for a Central Line (Spanish)
Caring for a Central Line (Arabic)
Giving Medications Safely at Home (English)
Giving Medications Safely at Home (Spanish)
Giving Medications Safely at Home (Arabic)
Childhood Cancer Awareness
Childhood Cancer Awareness Month
Five Ways to Support Families Dealing with Childhood Cancer
Determined to Get Back in the Game
Cancer Diagnosis Cant Shake These First-time Parents
What Specialists Does a Child See When Diagnosed with Cancer?
Mahra Beats Cancer and Avoids Amputation
Infographic-four-things-you-need-to-know-about-childhood-cancer
Four Things on the Horizon
For Physicians
Pediatric Neuro-Oncology Clinical Fellowship
Clinical Training
Research and Training
Clinical Trials & Research
How to Apply
Our eNewsletter
Fellows of 2014
International Society of Paediatric Oncology (SIOP) - 2020
American Society of Pediatric Hematology/Oncology Conference - 2021
Fellows of 2015
Fellows of 2016
2017 Pediatric Hematology/Oncology Fellows
Flexibility and Special Programs
Fellowship Program Leadership
Diversity and Inclusion
Meet Our Fellows
Fellow Life
Salary and Benefits
Faculty and Fellow Publications on Diversity, Equity, and Inclusion
2018 Pediatric Hematology/Oncology Fellows
Referrals and Second Opinions
Clinical Trials & Research
Our Fellowship Program
Pediatric Neuro-Oncology Clinical Fellowship
Fellows of 2014
Fellows of 2015
Fellows of 2016
2017 Pediatric Hematology/Oncology Fellows
Fellowship Program Leadership
Faculty and Fellow Publications on Diversity, Equity, and Inclusion
2018 Pediatric Hematology/Oncology Fellows
Meet Our Fellows
How to Apply
Clinical Training
Pediatric Neuro-Oncology Clinical Fellowship
Research and Training
Diversity and Inclusion
Fellow Life
Salary and Benefits
Flexibility and Special Programs
Program Leadership
Continuing Medical Education
Newsletter Sign Up
Affiliations and Consortia
Clinical Trials
Clinical Trials Results
Clinical Trials Detail
Clinical Trials
MyResults
Find a Doctor
Find a Doctor
Find Doctor Details
Find Doctor Results
News
Childhood cancer deaths: Brain cancer overtakes leukemia as top cause
Finally, hope for a young patient with CGD
Fighting genetic disease with help of HIV virus
Research into basic workings of immune system points to way of improving therapies for cancer and chronic infection
Scientists tackle DIPG, a lethal childhood brain cancer
Gene therapy offers hope for treatment of sickle cell anemia
Boston Children’s hires a chief scientific officer
The role of early phase clinical trials in end-of-life care for children
Intimate photos show young Guatemalan boy’s journey through cancer
Os pequenos herois que venceram o cancer
Children with Down syndrome and acute lymphoblastic leukemia
Deaths in cancer trials remain mystery for promising therapy
Pioneering doctor reflects on gene therapy’s trajectory
Sickle cell disease: An unpredictable adversary
Applying local knowledge
Gene therapy trial gives Coopersville toddler second chance at life
Precision medicine advances pediatric brain tumor diagnosis and treatment
In overhauling Obamacare the details matter
It’s not an even playing field
Travel dreams fulfilled for 9-year-old with terminal cancer
Stem-cell-derived cells flag possible new treatment for Diamond-Blackfan anemia
From moving mountains to climbing mountains, Fulton native seeks to redefine ‘possible’
The Lifesaving Care Act
Martial arts instructors volunteer with kids fighting cancer
One boy’s cure raises hopes and questions about gene therapy for sickle cell disease
How a child made scientists think of cytokines as knobs instead of switches
How dogs may help fight bone cancer
MIT Tech Review gene therapy
Dana-Farber/Boston Children's again named a top national pediatric cancer program
Novel CRISPR-Cas9 genetic screening approach enables discovery of new drug targets to aid cancer immunotherapy
Dana-Farber/Boston Children's responds to FDA approval of CAR-T cell therapy
Gene therapy halts progression of cerebral adrenoleukodystrophy in clinical trial
Two Dana-Farber/Boston Children's faculty members elected to National Academy of Medicine
A new gene therapy transplantation technique could improve treatment of neurodegenerative disease
Bursting with gene therapies and other innovative treatments, the overall survival rate for our blood and marrow transplant patients is exceeding expectations
Dana-Farber/Boston Children’s researcher is part of a new Stand Up To Cancer campaign with Marvel Studios’ Avengers and American Airlines
Pioneering hematologist to receive 2018 Nemmers Prize in Medical Science
Dana-Farber/Boston Children's again ranked among the top national pediatric cancer programs
Vietnamese boy thrives after gene therapy for Wiskott-Aldrich syndrome
The space between heartache and happiness: Two sons with adrenoleukodystrophy and a gene therapy clinical trial
New gene therapy clinical trial offers hope for sickle cell disease
Leslie Kean, MD, PhD, joins Dana-Farber/Boston Children's Stem Cell Transplantation program
MATCHing precision medicine to all kids with cancer
Fishing for new leads in rare mucosal melanoma
In zebrafish, a way to find new cancer therapies, targeting tumor promoters
Solving the DIPG puzzle a single cell at a time
Probing the brain’s earliest development, with a detour into rare childhood cancers
A bold strategy to enhance CAR T-cell therapies, capable of targeting DIPG and other tough-to-treat cancers
Zeroing in on the fetal-to-adult hemoglobin switch and a new way to combat sickle cell disease
A breakthrough in our understanding of how red blood cells develop
Cancer researchers hit a bullseye with a new drug target for Ewing sarcoma
Dulling cancer therapy’s double-edged sword: A new way to block tumor recurrence
New gene therapy strategy for sickle cell disease shows early promise in humans
Boston Children’s Hospital to receive $1.5M to initiate basic work to expand gene therapy treatment of sickle cell disease into developing countries
CRISPR-Cas9 screen opens new targets for Ewing sarcoma, other childhood cancers
Multi-center study led by Dana-Farber/Boston Children's contributes to FDA approval of a new treatment for acute lymphoblastic leukemia
Transplants from any donor without toxicity
Scott Armstrong, MD, PhD, recognized by ISSCR for contributions to basic and translational research in hematological disorders
Dana-Farber/Boston Children's Brian D. Crompton, MD, awarded research grant by the Go4theGoal Foundation
Researchers at Dana-Farber/Boston Children's and UMass Medical School optimize gene editing for sickle cell disease and beta thalassemia
Children with cancer wait an average of 6.5 years longer than adults to access new targeted drugs, finds study at Dana-Farber/Boston Children’s
Lynda M. Vrooman to present findings from Dana-Farber/Boston Children’s clinical trial that led to FDA approval of novel drug for treatment of ALL in young patients
Team led by Dana-Farber/Boston Children’s Kimberly Stegmaier receives SU2C Sharp Award from Stand Up To Cancer
Katherine E. Warren, MD, joins Dana-Farber/Boston Children’s as Clinical Director for Pediatric Neuro-Oncology
Dana-Farber/Boston Children's nation’s #1 pediatric cancer program
Leonard Zon, MD, honored by the American Society of Hematology for Outstanding Mentorship
“Stapled” antimicrobial peptides could combat antibiotic resistance
Stuart Orkin and Daniel Bauer receive funding for sickle cell disease research from the Doris Duke Charitable Foundation
Dana-Farber/Boston Children's launches first DIPG Brain Tumor Consortium
Dana-Farber/Boston Children’s Hojun Li named a 2020 Scholar Award Recipient by the American Society of Hematology
Dana-Farber/Boston Children’s faculty named 2020 Top Doctors
Stuart Orkin named 2020 King Faisal Prize Laureate in Medicine
The Osteosarcoma Institute to fund clinical trial in recurrent osteosarcoma at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
Shimamura named recipient of the 2020 Frank A. Oski Memorial Lectureship from ASPHO
Count Me In launches Osteosarcoma Project
Hass-Kogan receives funding for new DIPG-specific research project from Defeat DIPG and ChadTough
Dana-Farber/Boston Children’s receives $200,000 grant from Hyundai Hope On Wheels to support COVID-19 testing
Bauer earns Outstanding New Investigator Award from ASGCT
Massive study reveals how 'hypermutated' malignant brain tumors with many mutations escape chemotherapy and immunotherapy
2020 Harrington Prize awarded to Dr. Stuart H. Orkin
Pioneering a ‘Staple’ Approach for Treating COVID-19
Pediatric neurosurgeon Lissa Baird, MD, joins Dana-Farber/Boston Children’s
Population-based registry data identifies novel cancer patterns in families of childhood cancer patients
Dana-Farber/Boston Children's named a top pediatric cancer program
Amazon surprises Dana-Farber/Boston Children’s with a $500,000 donation during Childhood Cancer Awareness Month
Dana-Farber/Boston Children's Faculty Named 2021 Top Doctors
Stuart H. Orkin Receives the 2021 ISSCR Tobias Lecture Award
In landmark study, an arthritis drug appears to prevent deadly acute graft-versus-host disease after bone marrow transplant
Targeted therapy for children with leukemia can provide substantial benefit, study finds
Stuart Orkin receives $500,000 Gruber Genetics Prize for his groundbreaking research on the genetics of inherited blood disorders
Childhood cancer survivors, providers satisfied with video visits for long-term follow-up
Alex’s Lemonade Stand Foundation awards $4.95 million to Dana-Farber/Boston Children’s researchers as part of its Crazy 8 Initiative to advance pediatric cancer research
A. Thomas Look, MD, awarded 2021 Society of Memorial Sloan Kettering Prize recipient for contributions in pediatric oncology
Dana-Farber/Boston Children's again named a top pediatric cancer program
News
Williams honored for Outstanding Achievement by ASGCT
International Gene Therapy Trial Launched at Children's Hospital Boston
Potential gene therapy approach to sickle cell disease highlighted at ASH
The American Society of Hematology Elects New Leadership
Alex's Lemonade Stand Foundation awards $1.75 million grant to Dana-Farber Boston Children's Cancer and Blood Disorders Center
National Academy of Sciences honors Dana-Farber Boston Children's Cancer and Blood Disorders Center's Orkin
Drug shortage linked to greater risk of relapse in young Hodgkin lymphoma patients
Justin Bieber Dream Date Shines Light on Rare Pediatric Cancer
American Association for Cancer Research honors D'Andrea
Key mutations discovered for most common childhood brain cancer
Dana-Farber/Children's Hospital Cancer Center establishes training program with Egypt Cancer Network and Children's Cancer Hospital Egypt
Intensified chemotherapy shows promise for children with very high-risk form of leukemia
What's in a name
A new, faster route for pediatric clinical trials
Revealing new mutations in pediatric myelodysplastic syndromes
Delays in diagnosis worsen outlook for minority, uninsured pediatric retinoblastoma patients, study finds
Majority of children readmitted to hospital following transplant
Building a community around vascular anomalies research
Scientists find mutation driving pediatric brain tumors
Dana Farber Boston Children s Cancer and Blood Disorders Center launches new website
Seminar: Causes and effects of the shortage of oncology drugs
The High Price of Tanning
Optimism about Pediatric Cancer Care
Teaming with our twin in India, to take on hemophilia
Overcoming Drew’s blood disorder, together
Research registry reveals new mutations in rare childhood blood disorders
Summer Fun for Kids with Cancer
New Diller study
Dangers of Tanning Beds
Gene therapy’s time seems to have come
About-Us
Media Relations Policy
ReadyCam Studio
Gene Therapy Trial for Bubble Boy Syndrome
New Procedures Help Pediatric Cancer Patients With Future Fertility
Haematopoietic Stem Cell Transplants
Teenager Raises Thousands to Help Children with Vascular Anomalies
Five Things Parents of Children with Cancer Should Know
After Cancer Fertility Is Often Within Reach
The Survivorship Care Gap: After Childhood and AYA Cancers, How to Keep Survivors in Follow-Up Care
How to Help Your Child if a Classmate Has Cancer
Niña Batalla por Garnale al Cancer
The Gospel of Calle
Newly Discovered Gene Regulator Could Precisely Target Sickle Cell Disease
Survivors of Pediatric Brain Tumors Share a Special Bond
Dr Joanne Wolfe wins American Cancer Society Pathfinder Award
Martin Walsh's Childhood Marked by Cancer Fight
Bluebird Bio Advances Experimental Drug for Genetic Brain Disorder
Patricia Branowicki Elected to American Academy of Nursing
'Care Bundle’ Prevents Central Line-Associated Bloodstream Infections in Ambulatory Pediatric Cancer Patients
Young Warrior Shares His Story
Dana-Farber/Boston Children’s physicians among Boston Magazine’s Top Doctors 2013
International gene therapy trial for bubble boy disease shows promising early results
Rare cause of anemia in newborns often overlooked
Less Painful Drug Delivery for Pediatric Leukemia Patients is Safe, Effective, Research Suggests
Discovery holds promise for bubble boy patients
Gene therapy keeps bubble boy disease at bay in 8 children
My Sportsman: Nebraska Fan Jack Hoffman
Bubble Boy Disease Could Have a Cure
Mom, Son Battle Cancer Together with Inspiration and Teamwork
Study: Eating Nuts in Pregnancy May Lower Child’s Allergy Risk
Gisele Bundchen Visits Young Malden Girl Battling Cancer
Antipsychotic Drug Exhibits Cancer-Fighting Properties
Forbes Names Scientist One of “30 under 30” to Watch
Fertility After Treatment for Childhood Cancer
Fertility Among Survivors of Childhood Cancer
Lives Less Ordinary
Mutation Discovery May Improve Treatment for Rare Brain Tumor Type
Perseverance On and Off the High School Basketball Court
Sick Kids Need Faster Drug Testing
Long-term Survival Among Patients with Most Common Childhood Brain Tumor is High
Normal Enzyme Aids a Mutant One to Fuel Blood Cancer’s Growth
Alisha’s Strength Drives Cancer Fight
Working with Adult Survivors of Childhood Cancers
Hope Grows for Sickle Cell Disease Patients
Vermont Girl Gets Second Bone Marrow Transplant
Sick Vt. Kids Highlight Need for Bone Marrow Donors
Attleboro Police Make Room for a Middleborough Boy with Cancer
NH Boy Adopted from Ethiopia Finds Bone Marrow Match with African Siblings
Scientists Find Potential Drug Targets in Deadly Pediatric Brain Tumors
Gene Linked to Pediatric Kidney Cancer Suggests New Strategies for Kidney Regeneration
Physician Advocates for Palliative Care Bill on Beacon Hill
High School Athlete Shows Strength On-field and Off
Medical Education to Fight Global Cancer
Children with Low-grade Glioma Enjoy Long-term Survival
Nurse Lauded for Efforts with Patients
Siblings Arrive from Ethiopia to Try and Save Brother's Life
Researchers Uncover Link Between Down Syndrome and Childhood Leukemia
Billerica High Cell-out to Help Boy with Leukemia Worthy of a Standing ‘O’
University Rallies for Student Fighting Cancer
In Children with Cancer, Navy SEALS Find “Like-Minded” Warriors
Training Community-Based Pediatricians in Palliative Care
Preventing Infections in Outpatients Caring for Central Lines at Home
Study Calls for Revisiting Guidelines for Screening Childhood Cancer Survivors at Risk of Congestive Heart Failure
US News Names Dana-Farber Boston Children’s #1
Mayor Walsh Reflects on his Childhood Cancer before Audience of Cancer Survivors
Cancer Can’t Stop this Dorchester Teenager
In Cancer’s Aftermath, Young Adults Find Support from Each Other
A Young Cancer Patient’s Take on “The Fault in Our Stars”
Exploring Scorpion Venom’s Potential to Treat Cancer
Just 16, Karina Moreira Battles Cancer in her Own Style
Researchers Say Study Underscores Importance of Newborn Screening for “Bubble Boy” Disease
Tips for Primary Care Physicians Treating Survivors of Childhood Cancer
Gene Therapy for “Bubble Boy” Disease Appears to be Effective and Safe
Blood Work
A Child Saved Becomes a Teen Hunting for Cures
Parents of Late Quincy Teen Watch “Fault in Our Stars” with Her Providers
Liberia’s Response to Ebola
David G. Nathan, MD, Wins Boston Children’s Hospital Inaugural Lifetime Impact Award
Researchers Take New Approach to Stop ‘Most Wanted’ Cancer Protein
Common Genetic Variations May Contribute to Treatment-related Cognitive Problems in Children with Leukemia
Stem Cell Transplant without Radiation or Chemotherapy Pre-treatment Shows Promise for Rare Bone Marrow Failure
The Bad Disease: Inside Egypt’s Children’s Cancer Hospital
Unlocking the Secrets of Pediatric Cancers can Help Doctors Treat Children and Adults
Nine-year-old with Brain Tumor gets to Finish Concert with Friends
Q&A with David Williams
Family of Infant with AML Goes Home for Christmas
Imaging Captures How Blood Stem Cells Take Root
Cancer Care for the Developing World
Boston Hospitals Pave Way for Precision Medicine
Five Things Pediatricians Should Know About Children Who’ve Had Cancer
Palliative Care Eases the Burden of Serious Illness
The Late Effects of Childhood Cancer
Promising Drug Target Identified in Medulloblastoma
Phase I Trial of Immunotherapy Opens for Children with Relapsed or Treatment-resistant Leukemia
Discussing Child’s Cancer Prognosis More Likely to Produce Peace of Mind and Decrease Anxiety in Parents
U.S. News Names Dana-Farber Boston Children’s #1 Pediatric Cancer Program
Gene Editing Study Reveals Possible Achilles Heel of Sickle Cell Disease
Almost One Third of Families of Children with Cancer Have Unmet Basic Needs During Treatment
Disparities in Outcomes for Children with Rare Eye Cancer Suggest Unequal Access to Primary Care
Study Uses Gene Editing to Take Brakes Off Lab-based Red Blood Cell Production
Children with Childhood Leukemia Benefit from Prophylactic Antibiotics
Early Gene Therapy Results in Wiskott-Aldrich Syndrome Promising
Therapy Directed Against Platelets Does Not Significantly Reduce Painful Crises in Sickle Cell Disease
Studies highlight new drug targets or compounds for acute myeloid leukemia
Special holiday concert features young violinist and surgeon who removed her brain tumor
More than two-thirds of teen and young adult cancer patients facing end of life use aggressive measures
Genetic Sequencing Can Help Guide Treatment in Children with Solid Tumors
Genetic Cause Identified in Rare Pediatric Brain Tumor
Childhood leukemia patients from high-poverty areas more likely to suffer early relapse
Study explores how high-fat diet influences colon cancer
Amazing Allison: A young 'pioneer' and the Boston doctors who saved her
The Coalition for Pediatric Medical Research: Recommended Pediatric Priorities for the Cancer Moonshot Initiative
Making a difference: Treating sickle cell disease in Liberia
Young adult survivors of childhood cancer report
Evidence suggesting link between cancer and light therapy
Q & A: Making sense of new research on possible link between phototherapy for newborn jaundice and cancer
Brave boy donates bone marrow to sister fighting leukemia
Science commentary explores ways to pay for success in gene therapy
Genetic treatments for sickle cell
We’ve known for 50 years what causes sickle cell disease. Where’s the cure?
Dual stem-cell transplant improves outlook for children with high-risk neuroblastoma
Dana-Farber Boston Children’s remains nation’s #1 pediatric cancer program
Make children’s cancer research a ‘moonshot’ priority
How drug companies use gifts and internships to reach valuable hemophilia patients
Gene therapy trial wrenches families as one child’s death saves another
Biden should take a note from the original moonshot: Focus on just one cancer
Finding a cure wouldn’t mean we’ve defeated cancer
Outpatient bloodstream infections costly for pediatric stem cell transplant and cancer patients
BCL11A-based gene therapy for sickle cell disease passes key preclinical test
Discovery offers prospect of shorter treatment and cure for chronic myelogenous leukemia
America is great at beating childhood cancer and it’s about to get better
What the cancer moonshot might mean for kids
Patriots’ Nate Solder seeks normalcy after hellish year
Contact Us
Contact Us
Request an Appointment
Refer a Patient
Second Opinions
General Inquiries
Directions and Parking